2019
DOI: 10.1002/mds.27736
|View full text |Cite
|
Sign up to set email alerts
|

The interindividual variability of transcranial magnetic stimulation effects: Implications for diagnostic use in movement disorders

Abstract: Background A large number of methods have been described that use transcranial magnetic stimulation to probe the physiology of the human motor cortex. Since the 1990s, hundreds of papers have used them to investigate neurophysiological signatures of different types of movement disorders. However, in recent years there has been increasing recognition of the interindividual variability of these measures and a focus on estimating their reliability and reproducibility. Although this work has been carried out in he… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

4
36
0

Year Published

2019
2019
2024
2024

Publication Types

Select...
8
1

Relationship

3
6

Authors

Journals

citations
Cited by 46 publications
(40 citation statements)
references
References 186 publications
(401 reference statements)
4
36
0
Order By: Relevance
“…There are several limitations of MEPs as a clinical biomarker. A recent paper investigating the use of MEP measures in movement disorders, specifically Parkinson's disease, dystonia, Tourette syndrome, Huntington Disease and essential tremor, found discrepancies between studies reporting “canonical” MEP findings for these conditions (56). Similar to our findings, the authors found inconsistencies in methodology, diagnostic criteria for inclusion, study participants' disease stages, and small sample sizes contributed to weaker evidence for the use of MEPs for diagnosis and differential diagnosis in movement disorders.…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…There are several limitations of MEPs as a clinical biomarker. A recent paper investigating the use of MEP measures in movement disorders, specifically Parkinson's disease, dystonia, Tourette syndrome, Huntington Disease and essential tremor, found discrepancies between studies reporting “canonical” MEP findings for these conditions (56). Similar to our findings, the authors found inconsistencies in methodology, diagnostic criteria for inclusion, study participants' disease stages, and small sample sizes contributed to weaker evidence for the use of MEPs for diagnosis and differential diagnosis in movement disorders.…”
Section: Discussionmentioning
confidence: 99%
“…∘ Low to moderate reliability of some MEP measures, e.g., MEP recruitment, cortical silence period, intracortical facilitation (56)…”
Section: Discussionmentioning
confidence: 99%
“…In summary, our data show for the first time that stimulation of DLPFC does not influence ipsilateral motor cortex activity both while participants were at rest and contracting the target muscle. Although caution should be used when interpreting findings with TMS [68], it would be fruitful if future work uses the conditioning-test ds TMS approach described here to probe how DLPFC-M1 interactions dynamically change during higher-level aspects of motor control across the lifespan and how these interactions are affected by abnormalities of motor and cognitive function in pathological conditions such as stroke, Parkinson’s, and Alzheimer’s disease.…”
Section: Discussionmentioning
confidence: 99%
“…It is likely that we have been sampling a highly variable outcome parameters with numbers that are too low to adequately power studies. Recent reviews have described the belief in the plasticity hypothesis in dystonia as ‘canonical’ rather than evidence based (Conte et al 2019 ; Latorre et al 2019 ). Our collective commitment to plasticity as a hypothesis for dystonia pathophysiology will lead to both implicit and explicit bias (e.g.…”
Section: Reappraising the Role Of Plasticity In Dystoniamentioning
confidence: 99%